299 related articles for article (PubMed ID: 24361268)
21. Optimisation of cosolvent concentration for topical drug delivery III--influence of lipophilic vehicles on ibuprofen permeation.
Watkinson RM; Guy RH; Oliveira G; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2011; 24(1):22-6. PubMed ID: 20616625
[TBL] [Abstract][Full Text] [Related]
22. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
23. Mass transport model through the skin by microencapsulation system.
Carreras N; Alonso C; Martí M; Lis MJ
J Microencapsul; 2015; 32(4):358-63. PubMed ID: 26004367
[TBL] [Abstract][Full Text] [Related]
24. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
25. Development of a new nanovesicle formulation as transdermal carrier: formulation, physicochemical characterization, permeation studies and anti-inflammatory activity.
Gaur PK; Mishra S; Purohit S; Kumar Y; Bhandari A
Artif Cells Nanomed Biotechnol; 2014 Oct; 42(5):323-30. PubMed ID: 23944163
[TBL] [Abstract][Full Text] [Related]
26. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
[TBL] [Abstract][Full Text] [Related]
27. Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.
Duangjit S; Pamornpathomkul B; Opanasopit P; Rojanarata T; Obata Y; Takayama K; Ngawhirunpat T
Int J Nanomedicine; 2014; 9():2005-17. PubMed ID: 24851047
[TBL] [Abstract][Full Text] [Related]
28. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
[TBL] [Abstract][Full Text] [Related]
29. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
[TBL] [Abstract][Full Text] [Related]
30. Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation.
Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A
Drug Dev Ind Pharm; 2014 Apr; 40(4):568-76. PubMed ID: 23547761
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
32. Numerical modelling of transdermal delivery from matrix systems: parametric study and experimental validation with silicone matrices.
Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Másson M
J Pharm Sci; 2014 Aug; 103(8):2366-75. PubMed ID: 24984880
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
Hu L; Yang J; Liu W; Li L
Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
[TBL] [Abstract][Full Text] [Related]
34. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Al Shuwaili AH; Rasool BK; Abdulrasool AA
Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
[TBL] [Abstract][Full Text] [Related]
35. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
36. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
37. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
40. The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo.
Brain KR; Green DM; Dykes PJ; Marks R; Bola TS
Skin Pharmacol Physiol; 2006; 19(1):17-21. PubMed ID: 16247245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
